OTCMKTS:CNTMF - Cansortium Stock Price, News & Analysis

0.00 (0.00 %)
(As of 08/22/2019 10:05 AM ET)
Today's Range
Now: $1.05
50-Day Range
MA: $1.28
52-Week Range
Now: $1.05
Volume14,110 shs
Average Volume60,691 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
Cansortium Inc., through its subsidiaries, produces and sells medical cannabis in the United States. It operates cultivation, processing, and dispensary facilities in Florida, Texas, and Puerto Rico; and a dispensary license in Pennsylvania. The company was founded in 2015 and is headquartered in Miami, Florida.

Industry, Sector and Symbol

Industry Drug Manufacturers - Specialty & Generic



Sales & Book Value

Annual SalesN/A



Next Earnings DateN/A
OptionableNot Optionable

Receive CNTMF News and Ratings via Email

Sign-up to receive the latest news and ratings for CNTMF and its competitors with MarketBeat's FREE daily newsletter.

Cansortium (OTCMKTS:CNTMF) Frequently Asked Questions

What is Cansortium's stock symbol?

Cansortium trades on the OTCMKTS under the ticker symbol "CNTMF."

What is the consensus analysts' recommendation for Cansortium?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cansortium in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Cansortium.

Has Cansortium been receiving favorable news coverage?

Media stories about CNTMF stock have trended positive this week, InfoTrie Sentiment reports. The research firm identifies negative and positive news coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Cansortium earned a coverage optimism score of 2.5 on InfoTrie's scale. They also assigned media stories about the company a news buzz of 6.0 out of 10, indicating that recent news coverage is somewhat likely to have an effect on the stock's share price in the next several days. View News Stories for Cansortium.

Who are some of Cansortium's key competitors?

What other stocks do shareholders of Cansortium own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Cansortium investors own include KushCo (KSHB), Harvest Health & Recreation (HRVSF), IQIYI (IQ), Stitch Fix (SFIX), Aphria (APHA), Auxly Cannabis Group (CBWTF), Charlotte's Web (CWBHF), Namaste Technologies (NXTTF), TENCENT HOLDING/ADR (TCEHY) and HEXO (HEXO).

Who are Cansortium's key executives?

Cansortium's management team includes the folowing people:
  • Mr. Jose Javier Hidalgo, CEO & Director
  • Mr. Henry Batievsky, CFO & Director
  • Mr. Patrick Maloy, COO & Director
  • Dr. Jennifer McCafferty-Fernandez, Chief Science Officer
  • Mr. Jeffrey Reath, Exec. VP of Fin. & Investor Relations Corp. Sec. and Director

How do I buy shares of Cansortium?

Shares of CNTMF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Cansortium's stock price today?

One share of CNTMF stock can currently be purchased for approximately $1.05.

What is Cansortium's official website?

The official website for Cansortium is http://www.cansortium.com/.

How can I contact Cansortium?

The company can be reached via phone at 305-902-2720.

MarketBeat Community Rating for Cansortium (OTCMKTS CNTMF)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  7 (Vote Outperform)
Underperform Votes:  7 (Vote Underperform)
Total Votes:  14
MarketBeat's community ratings are surveys of what our community members think about Cansortium and other stocks. Vote "Outperform" if you believe CNTMF will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CNTMF will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 8/22/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel